|A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost …|
YF Chen, P Jobanputra, P Barton, S Jowett, S Bryan, W Clark, A Fry-Smith, ...
Health technology assessment (Winchester, England) 10 (42), iii-iv, xi, 2006
|Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and …|
YF Chen, P Jobanputra, P Barton, S Bryan, A Fry-Smith, G Harris, ...
Health technology assessment (Winchester, England) 12 (11), 1-278, iii, 2008
|Validity of Euroqol—A generic health status instrument—in patients with rheumatoid arthritis: Economic and Health Outcomes Research Group|
NP Hurst, P Jobanputra, M Hunter, M Lambert, A Lochhead, H Brown
Oxford University Press 33 (7), 655-662, 1994
|Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic …|
K Malottki, P Barton, A Tsourapas, AO Uthman, Z Liu, K Routh, ...
NIHR Health Technology Assessment programme: Executive Summaries, 2011
|Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis|
A Filer, P De Pablo, G Allen, P Nightingale, A Jordan, P Jobanputra, ...
Annals of the rheumatic diseases 70 (3), 500-507, 2011
|Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology …|
MM Soliman, DM Ashcroft, KD Watson, M Lunt, DPM Symmons, KL Hyrich
Annals of the rheumatic diseases 70 (4), 583-589, 2011
|Effects of intermittent pressure-induced strain on the electrophysiology of cultured human chondrocytes: evidence for the presence of stretch-activated membrane ion channels|
M Wright, P Jobanputra, C Bavington, DM Salter, G Nuki
Clinical Science 90 (1), 61-71, 1996
|Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation.|
C Clar, E Cummins, L McIntyre, S Thomas, J Lamb, L Bain, P Jobanputra, ...
Health Technology Assessment (Winchester, England) 9 (47), iii-iv, ix, 2005
|Hyperpolarisation of cultured human chondrocytes following cyclical pressure‐induced strain: Evidence of a role for α5β1 integrin as a chondrocyte mechanoreceptor|
MO Wright, K Nishida, C Bavington, JL Godolphin, E Dunne, S Walmsley, ...
Journal of orthopaedic research 15 (5), 742-747, 1997
|A pragmatic randomised controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis|
L Eversden, F Maggs, P Nightingale, P Jobanputra
BMC musculoskeletal disorders 8 (1), 1-7, 2007
|The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.|
P Barton, P Jobanputra, J Wilson, S Bryan, A Burls
Health technology assessment (Winchester, England) 8 (11), iii, 1-91, 2004
|The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation|
P Jobanputra, P Barton, S Bryan, A Burls
Health Technol Assess 6 (21), 1-110, 2002
|Certolizumab pegol (CDP870) for rheumatoid arthritis in adults|
VR Garcia, A Burls, JB Cabello, PV Casasempere, S Bort‐Marti, JA Bernal
Cochrane Database of Systematic Reviews, 2017
|The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.|
W Clark, P Jobanputra, P Barton, A Burls
Health technology assessment (Winchester, England) 8 (18), iii-iv, ix, 2004
|Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)|
AL Herrick, X Pan, S Peytrignet, M Lunt, R Hesselstrand, L Mouthon, ...
Annals of the rheumatic diseases 76 (7), 1207-1218, 2017
|A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis|
P Jobanputra, J Wilson, K Douglas, A Burls
Rheumatology 43 (2), 206-210, 2004
|Clinical Utility of Random Anti–Tumor Necrosis Factor Drug–Level Testing and Measurement of Antidrug Antibodies on the Long‐Term Treatment Response in Rheumatoid Arthritis|
M Jani, H Chinoy, RB Warren, CEM Griffiths, D Plant, B Fu, AW Morgan, ...
Arthritis & Rheumatology 67 (8), 2011-2019, 2015
|Foot orthoses for patellofemoral pain in adults|
M Hossain, P Alexander, A Burls, P Jobanputra
Cochrane Database of Systematic Reviews, 2011
|Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review|
P Jobanputra, D Parry, A Fry-Smith, A Burls
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2001
|Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events|
P Jobanputra, R Amarasena, F Maggs, D Homer, S Bowman, E Rankin, ...
BMC musculoskeletal disorders 9 (1), 1-7, 2008